Significance of lung shrinkage on CXR as a prognostic factor in patients with idiopathic pulmonary fibrosis

Respirology

Volumn 8, Issue 3, 2003, Pages 351-358

  Kawabata, Hidenobu ^a,b   Nagai, Sonoko ^a   Hayashi, Michio ^a   Nakamura, Hiroshi ^a   Nagao, Taisi ^a   Shigematsu, Michio ^a   Kitaichi, Masanori ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Idiopathic pulmonary fibrosis; Lung shrinkage; Prognostic factors; Radiographic findings; Survival; Usual interstitial pneumonia

Indexed keywords

ADULT; AGED; ARTERIAL GAS; ARTICLE; AUTOPSY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; OBSERVER VARIATION; PROGNOSIS; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0141625081     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00469.x     Document Type: Article

References (27)

1. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N. Engl. J. Med. 1978; 298: 801-9.
2. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am. J. Med. 1990; 88: 396-404.
3. Johnston IDA, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997; 52: 38-44.
4. Gay SE, Kazerooni EA, Toews GB et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am. J. Respir. Crit. Care Med. 1998; 157: 1063-72.
5. Schwartz DA, Helmers RA, Galvin JR et al. Determinants of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1994; 149: 450-4.
6. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-8.
7. Izumi T, Nagai S, Kondo Y, Tamura M. Ten-year follow-up of 222 patients with idiopathic pulmonary fibrosis - a nation-wide survey report in Japan. Am. Rev. Respir. Dis. 1993; 145: A218.
8. Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med, 1998; 157: 199-203.
9. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-80.
10. Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983; 38: 349-55.
11. Gaensler E, Carrington CB, Coutu RE, Fitzgerald MX. Radiographic-physiographic-pathologic correlation in interstitial pneumonias. Prog. Respir. Res. 1975; 8: 223-41.
12. Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972; 27: 535-42.
13. Schwartz DA, Van Fossen DS, Davis CS et al. Determinants of progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1994; 149: 444-9.
14. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung disease of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N. Engl. J. Med. 1984; 310: 154-66.
15. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1986; 133: 97-103.
16. Anonymous. UICC/Cincinnati classification of the radiographic appearances of pneumoconioses. A cooperative study by the UICC committee. Chest 1970; 58: 57-67.
17. Feinstein AR. Multivariable Analysis: An Introduction. Yale University Press, New Haven, 1990; 370-430.
18. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and idiopathic bronchiolitis obliterans organizing pneumonia. Eur. Respir. J. 1998; 12: 1010-19.
19. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 1998; 157: 1301-15.
20. Colby TV, Lombard C, Yousem SA, Kitaichi M. Atlas of Pulmonary Surgical Pathology. W.B. Saunders Company, Philadelphia, 1991; 228.
21. Doherty MJ, Pearson MG, O'Grady EA, Pellegrini V, Calverley PMA. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52: 998-1002.
22. Fulmer JD, Roberts WC, von Gal ER, Crystal RG. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J. Clin. Invest. 1979; 63: 665-76.
23. Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1991; 144: 504-6.
24. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997; 155: 242-8.
25. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284-9.
26. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998; 113: 396-400.
27. Nagao T, Nagai S, Kitaichi M, Izumi T. Are histological changes found in parallel with the progression of IPF/UIP? (abstract). Am. J. Respir. Crit. Care Med. 1998; 157: A69.